EBV ImmuneSelect Peptide Pool Premium

Product Overview

Description

The EBV peptide pool contains 44 peptides (8-21mer) from Human herpesvirus 4 (Epstein Barr virus), derived from the following protein

  • BARF1 protein
  • BZLF1
  • DNA polymerase catalytic subunit
  • EBNA-1 (Epstein-Barr nuclear antigen 1)
  • EBNA-2
  • EBNA-3A
  • EBNA-3B
  • EBNA-6
  • Glycoprotein GP110 precursor (MTP, p140)
  • Large tegument protein deneddylase
  • LMP1 (Latent membrane protein 1)
  • LMP2A/B
  • Envelope membrane glycoprotein GP350
  • Transcription activator BRLF1

 

The peptide sequences are a mixture of MHC class–I & MHC class–II epitopes.  The purity of each peptide is ≥90% (HPLC-MS).

 

Application

The in-vitro stimulation of Peripheral Blood Mononuclear Cells (PBMCs) with EBV ImmuneSelect Peptide Pool activates memory T cells specific to the virus, leading to cytokine secretion and the increased expression of specific surface markers.

£195.00

Product Details

Amount

7 nmol/peptide (approx. 11.6 ug), for the stimulation of up to 1.10^8 cells

Purity

≥90% (HPLC-MS)

Delivery Format

Freeze-dried in a glass vial

Application(s)

Cell Stimulation

Shipping and Storage

Store at -20 °C or below